Sarepta Therapeutics, Inc. (SRPT)
17.50
-0.07
(-0.40%)
USD |
NASDAQ |
Oct 02, 16:00
17.50
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Market Cap : 1.848B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.848B |
| October 01, 2026 | 1.856B |
| September 30, 2026 | 1.924B |
| September 29, 2026 | 1.969B |
| September 28, 2026 | 1.986B |
| September 25, 2026 | 1.972B |
| September 24, 2026 | 1.942B |
| September 23, 2026 | 2.002B |
| September 22, 2026 | 2.198B |
| September 21, 2026 | 2.127B |
| September 18, 2026 | 2.124B |
| September 17, 2026 | 2.183B |
| September 16, 2026 | 2.087B |
| September 15, 2026 | 2.189B |
| September 14, 2026 | 2.210B |
| September 11, 2026 | 2.160B |
| September 10, 2026 | 2.167B |
| September 09, 2026 | 2.326B |
| September 08, 2026 | 2.212B |
| September 04, 2026 | 2.377B |
| September 03, 2026 | 2.428B |
| September 02, 2026 | 2.452B |
| September 01, 2026 | 2.253B |
| August 31, 2026 | 2.221B |
| August 28, 2026 | 2.203B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.280B |
| August 26, 2026 | 2.055B |
| August 25, 2026 | 1.998B |
| August 24, 2026 | 1.915B |
| August 21, 2026 | 1.985B |
| August 20, 2026 | 2.030B |
| August 19, 2026 | 2.084B |
| August 18, 2026 | 1.903B |
| August 17, 2026 | 1.920B |
| August 14, 2026 | 1.912B |
| August 13, 2026 | 1.946B |
| August 12, 2026 | 1.941B |
| August 11, 2026 | 1.924B |
| August 10, 2026 | 1.815B |
| August 07, 2026 | 1.772B |
| August 06, 2026 | 1.772B |
| August 05, 2026 | 1.683B |
| August 04, 2026 | 1.731B |
| August 03, 2026 | 1.677B |
| July 31, 2026 | 1.569B |
| July 30, 2026 | 1.643B |
| July 29, 2026 | 1.640B |
| July 28, 2026 | 1.629B |
| July 27, 2026 | 1.678B |
| July 24, 2026 | 1.655B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 75.81B |
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Beam Therapeutics, Inc. | 2.530B |
| ImmunityBio, Inc. | 10.83B |
| Twist Bioscience Corp. | 11.82B |
Market Cap Related Metrics
| PS Ratio | 0.9581 |
| PEG Ratio | -0.0214 |
| Price to Book Value | 1.210 |
| Price to Free Cash Flow | 32.43 |
| Price | 17.50 |
| Earnings Yield | -16.56% |
| PEGY Ratio | -0.0214 |